ADMA Biologics
ADMA
#4481
Rank
A$3.20 B
Marketcap
A$13.46
Share price
11.58%
Change (1 day)
-58.26%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: A$3.20 Billion

As of March 2026 ADMA Biologics has a market cap of A$3.20 Billion. This makes ADMA Biologics the world's 4481th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.20 B-53.34%
2025A$6.86 B3.57%
2024A$6.63 B342.37%
2023A$1.49 B19.03%
2022A$1.25 B230.72%
2021A$0.38 B58.83%
2020A$0.23 B-29.25%
2019A$0.33 B115.51%
2018A$0.15 B-15.61%
2017A$0.18 B103.56%
2016A$91.53 M-22.87%
2015A$0.11 B-6.42%
2014A$0.12 B56.08%
2013A$81.25 M

End of Day market cap according to different sources

On Mar 28th, 2026 the market cap of ADMA Biologics was reported to be:

A$3.20 Billion
by Nasdaq info icon info icon
A$3.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
A$9.02 B 181.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$2.00 B-37.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$39.37 M-98.77%๐Ÿ‡บ๐Ÿ‡ธ USA